Pulling SEC filings + quote and writing the call…

Legend Biotech Corp
Next earnings Aug 10, 2026 (before open) · consensus $0.09 EPS, $370M rev
Mixed signals in the latest filings.
Legend Biotech Corp shows limited reported revenue.
No income data filed.
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Sources: SEC EDGAR (CIK 0001801198, latest 144 filed 2026-06-26) · EODHD · as of 6/20/2026, 7:25:08 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2026-03-25 | Huang Ying Chief Executive Officer | Sell | 9.94K @ $8.77 | $87.1K |
1044 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.